Literature DB >> 7605878

Plasma thrombomodulin levels in coronary sinus blood in patients with coronary artery disease.

K Hoshi1, T Inoue, H Kakoi, T Satoh, H Yamaguchi, Y Sakai, S Morooka, Y Takabatake.   

Abstract

Plasma thrombomodulin (TM) levels in coronary sinus blood were measured in 15 patients with coronary artery disease who underwent elective PTCA (group A). TM was also measured in eight patients with coronary artery disease (group B) and six patients without coronary artery disease (group C), who only underwent diagnostic coronary angiography. The baseline level was 21.6 +/- 3.4 U/ml in group A, and 21.0 +/- 4.9 in group B, and both levels were slightly higher (P < 0.05) than those in group C (15.1 +/- 3.3). In group A, the level increased to 27.5 +/- 8.3 (P < 0.01) immediately after PTCA and then returned to 22.2 +/- 5.1 by 24 h. In groups B and C, levels showed no change immediately after angiography. In group A, the percentage increase in the TM level immediately after PTCA from that before the procedure correlated with the number of balloon inflations (r = 0.76, P < 0.01). In conclusion, the plasma TM level in coronary sinus blood might indicate endothelial damage due to atherosclerotic coronary artery disease and an increase in the level after PTCA might directly indicate vascular injury by balloon inflation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605878     DOI: 10.1097/00001721-199504000-00007

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

1.  Victims of lethal hypothermia have decreased levels of thrombomodulin in myocardium and urine.

Authors:  Lasse Pakanen; Helena Kaija; Marja-Leena Kortelainen; Terttu Särkioja; Katja Porvari
Journal:  Int J Legal Med       Date:  2014-12-28       Impact factor: 2.686

2.  Increased levels of plasma thrombomodulin in patients with acute myocardial infarction who had thrombolytic therapy and achieved successful reperfusion.

Authors:  M Ileri; I Hisar; E Yetkin; F Koşar; S Cehreli; S Korkmaz; D Demirkan
Journal:  Clin Cardiol       Date:  2001-05       Impact factor: 2.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.